Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bingdu Wuyou, also known as Bingduqing Granules, is a Traditional Chinese Medicine (TCM) product developed by Shandong Green Leaf Natural Medicine Research and Development Co., Ltd. (a subsidiary of Luye Pharma) for the treatment of the common cold and influenza. It is a standardized herbal formulation composed of several botanical extracts, typically including *Lonicera japonica* (honeysuckle), *Scutellaria baicalensis* (baical skullcap), and *Forsythia suspensa*. These ingredients are traditionally recognized for their heat-clearing and detoxifying properties. Pharmacologically, the formulation exhibits broad-spectrum antiviral activity against respiratory viruses and possesses anti-inflammatory properties that help mitigate the systemic inflammatory response associated with viral infections. It is primarily indicated for symptoms such as fever, headache, cough, and sore throat associated with upper respiratory tract infections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bingduqing granules.